VAERS Explorer
Back to explore

Report #2895914

Received May 8, 2026

Office visitDisabled
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
55 yrs
State
FL
Recovered
Not recovered
Vaccinated
Oct 22, 2025
Onset
Oct 26, 2025
Days to onset
4
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUCELVAX)SEQIRUS, INC.UNK407009SYR / LA

Symptoms (10)

Angiotensin converting enzyme abnormalArthralgiaElectromyogram normalLaboratory test normalMagnetic resonance imaging normalMyalgiaNeck painNerve conduction studies normalPain in extremityX-ray normal

Symptom narrative

Bilateral bicept, forarm, shoulder and neck pain.

Current illness

None

Medical history

HIV

Other medications

None

Allergies

None

Lab data

12/02/25 ? Statin discontinued, likely in response to new musculoskeletal symptoms. 12/07/25 ? Treated with Methylprednisolone (corticosteroid) for inflammatory symptoms. 12/17/25 ? Laboratory workup performed; results within normal limits at that time. 02/17/26 ? Orthopedic evaluation with X-rays; no structural abnormality identified by orthopedic surgeon or neurosurgeon. 02/19/26 ? MRI performed. 02/24/26 ? Nerve conduction study (NCS) and EMG performed; no neurological abnormality identified. 03/04/26 ? Rheumatology consultation with comprehensive laboratory panel. ACE (angiotensin-converting enzyme) level markedly elevated at 330 U/L (reference range approximately 8?52 U/L), raising strong concern for systemic sarcoidosis. 04/20/26 ? Follow-up consultation with neurosurgeon; reviewed MRI findings and determined no structural or neurological abnormality sufficient to account for the patient's ongoing symptoms. 05/12/26 ? PET-CT scan scheduled as next diagnostic step to evaluate for sarcoidosis versus other granulomatous or lymphoproliferative disease. Treating physicians' assessment: Rheumatology and collaborating physicians consider the influenza vaccine a likely precipitating vector for the development of systemic sarcoidosis in this patient.